Crossmark

Pharmacological preconditioning with phosphodiestrase inhibitor: an answer to stem cell survival against ischemic injury through JAK/STAT signaling

Published Online: 2019-07-15

Published Print: 2020-03

Authors

Yadav, Manju

Kumari, Pooja

Yadav, Varsha

Kumar, Sanjay
Funding

Funding for this research was provided by:

National Institutes of Health (RO1 HL-087246)
License Information

Text and Data Mining valid from 2019-07-15

Version of Record valid from 2019-07-15
More Information

Article History

First Online: 15 July 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current